Security key
929033108
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 58,931,374
- Total 13F value
- $139,665,556
- Share change
- -561,559
- Put/Call ratio
- 5.6%
- SEC-reported price per share
- $2.37
- Number of holders
- 67
- Value change
- -$1,330,255
- Number of buys
- 29
- Number of sells
- 21
- Shares outstanding
- 48,114,688
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
67
Top holders
10
VOR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Vor Biopharma Inc. SEC filings
Vor Biopharma Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 929033108
Recent filing periods:
Ownership snapshot
Top reported holders of VOR - VOR BIOPHARMA INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 47%
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 47%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
47%
FMR LLC
16%
Paradigm Biocapital Advisors LP
13%
5AM Venture Management, LLC
13%
Laurion Capital Management LP
6.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
47%
|
$51,184,980
22,748,880 shares
|
— | 31 Dec 2023 |
| FMR LLC |
13F
Company
|
16%
|
$17,142,633
7,618,948 shares
|
— | 31 Dec 2023 |
| Paradigm Biocapital Advisors LP |
13F
Company
|
13%
|
$14,528,909
6,457,293 shares
|
— | 31 Dec 2023 |
| 5AM Venture Management, LLC |
13F
Company
|
13%
|
$14,313,877
6,361,723 shares
|
— | 31 Dec 2023 |
| Laurion Capital Management LP |
13F
Company
|
6.6%
|
$7,161,501
3,182,889 shares
|
— | 31 Dec 2023 |
| Artal Group S.A. |
13F
Company
|
4.9%
|
$5,282,000
2,347,424 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
67
Shares
58,931,374
Rows available
67
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
67
Q1 2024 holders
67
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend